Management Forum Logo

Presented by
Management Forum

The Pharma Mini MBA Training Course

A three-day accelerated management programme to give you the high-performance management skills of an MBA, designed specifically for pharmaceutical/biotechnology professionals and also applicable to medical device/animal health industries

15-17 May 2024
+ 31 July-2 August 2024, 6-8 November 2024 »

from £1199

Need help?  Enrol or reserve

Course overview

Working in the highly competitive pharmaceutical industry, with ever-increasing change and pressure, is probably one of the most challenging managerial roles of any industry today. This event has been especially designed to help you transcend these challenges by training you to become equipped to see the bigger picture in all aspects of your role. It will help you build your management skills for the future and prepare you to fulfil your ambitions.

The Pharma Mini MBA accelerated management programme is a distillation of the most valuable parts of an MBA, as applied to the pharmaceutical industry. It will provide you with practical management tools to apply in the workplace, as well as giving a real taste of an MBA course with pharmaceutical case studies from business schools.

Pharmaceutical industry context – business school pharmaceutical case studies on each module

This intensive three-day course will help you to translate your learning into new behaviours and improvements in your capability and performance and will work through live issues impacting on the industry and on you directly. The individual and group exercises will focus on pharmaceutical/biopharma/generic MBA case studies, and also on your own challenges and examples. The business school case studies will help give the ‘feel’ of a full MBA and help you understand more about the strategies used in today’s pharmaceutical and associated industries.

The Pharma Mini MBA is also an invaluable guide to all that is best and most practical on an MBA course – with specific focus on the pharmaceutical sector. It is also of value either to gain the most useful aspects of an MBA or as an MBA taster, providing a foundation of the essential MBA elements to apply directly to your role. The pharmaceutical industry requires employees to focus on successful leadership and business management skills, which this programme is designed to give you.

This training course is part of our collection of Leadership & Management Training Courses which focus on leadership, innovation, strategy, communication, finance, problem solving and conflict management, to name a few key areas.

Key benefits of attending

MBA learning style of the programme

The Pharma Mini MBA learning style is ‘hands-on’ rather than academic. The programme is very practical, without being too theoretical, with industry-relevant case studies drawn from business school cases. The course covers the key areas of an MBA and applies these MBA tools and concepts to the pharmaceutical industry, providing you with a firm foundation of the essential MBA thinking and terminology. Three modules will be covered in just three days of interactive workshops to enhance the value of the course and, to minimise your time away from the office, there is also optional pre- and post-course work set by the programme director.

  • Develop your understanding of the key techniques of an MBA to apply to your work
  • Gain a greater understanding of the pharma industry, its drivers, challenges and opportunities
  • Hear about the latest strategic technology innovations being used and developed in the pharma industry
  • Understand what strategic thinking is and how to use strategy tools
  • Develop your leadership and strategic skills
  • Become more effective in coping with and managing change in the pharma industry
  • Explore the benefits and costs of doing an MBA
  • Take away a Mini MBA toolkit to apply to your job
  • Discuss and learn from real pharma industry case studies

 Pre-course work (sent out to delegates prior to the course)

  • Diagnostic questionnaire – your strategic competencies
  • Discussions of diagnostic output/other areas of value

Who should attend?

A ‘must-attend’ for professionals in the pharmaceutical/biopharma/medical device/animal health industries wishing to develop their business management skills for more senior levels and beyond mere technical ability. It will also help anyone thinking of studying for an MBA who would like an idea of what is involved. It is particularly beneficial to attend with a colleague to maximise the practical learning.

Enrol or reserve

The The Pharma Mini MBA course will cover:

Strategy and strategic challenges in the pharma industry

  • Strategy and strategic thinking and their importance in the pharma industry
  • Strategic analysis, planning and implementation
    • Environmental analysis
    • Understanding the competitive environment 
    • Strategic options
  • Applying the MBA toolkit
  • Stakeholders and their expectations in the pharma industry
  • Obtaining the value out of strategy in the pharma industry

Commercial management and leadership in the pharma industry

  • New product development and the target product profile
  • Portfolio management used in the pharma industry
  • Understanding business performance
  • The business plan
  • Diagnosing specific performance problems
  • Developing strategic alliances and collaborations in the pharma industry
  • Benefits, costs of doing an MBA and the different routes
  • The role of leadership
    • What are the core competencies of effective leaders in pharma? 
    • Leadership vs management
    • Leadership style and approaches in the pharma industry

Managing innovation in the pharma industry

  • Innovation approaches currently being adopted along the pharma value chain
  • Future innovations in pharma and the life science industries

Hot topics in market access strategy

Leading and implementing pharma strategy and change

  • Leading successful change
    • Diagnosis around change
    • How to create the conditions for successful change
    • Why people resist change and how to manage this
    • Change management including leading a structural reorganisation
    • Creating a team, department and organisation relevant to today’s pharma business needs
    • Team formation and development
  • Implementing strategy and change, essentials of planning and managing projects
    • Project management tools and techniques to use in implementing pharma projects
    • Applying key project management techniques to pharma projects
    • Understanding of cultural awareness to work more effectively with pharma colleagues

Practical application/review

  • Personal development action plan to apply the learning within your own organisation
  • Revisiting your competency assessment – what has shifted?
  • Recommended further reading
  • Practical application of tools (toolkit)

Enrol or reserve

Laura Brown
LB Training and Development Ltd

Dr Laura Brown MBA, BSc (Biochemistry), BSc (Psychology), PhD, Diploma in Clinical Science, FICR, is Chair of an international pharmaceutical management consultancy and course director and senior lecturer for the MSc in Clinical Research at the School of Pharmacy, University of Cardiff. She has also worked as an associate with Cranfield School of Management on the leadership module of the MBA programme and their strategic thinking courses.

Dr Brown worked for Cambridge Corporate Development, an international strategy consultancy, for seven years and has extensive experience in senior management roles in the pharmaceutical industry. She has worked for Wellcome, Hoechst Marion Roussel and Phoenix International and consulted internationally with numerous pharmaceutical companies in the EU, US, Singapore, China and India. She is co-author of several management books including Be Your Own Strategy Consultant, The Ultimate Book of Business Skills and Project Management for the Pharmaceutical Industry.

More details

Leela Barham
Leela Barham Economics Consulting Ltd

Leela Barham is a freelancer with a background in health economics and now works in academia, as a journalist and with all stakeholders in the health care system conducting research on the economics of health and pharmaceuticals. She has over 20 years of experience and has been published in both peer reviewed journals and the specialist pharmaceutical press. She also worked to support the UK government as it agreed the 2019 voluntary scheme for branded medicines pricing and access. 

More details

Oguz Ozden
PWC

Oguz is a strategy consultant in PwC’s Strategy& practice, leading large, complex and international transformations across the Pharma and Life Sciences sector. He has over 10 years of consulting experience in the sector having worked across various functions in Biotech, Pharma and Consumer Health as well as Pharmaceutical Wholesale.

More details

NEW higher discounts for multiple bookings - bring your colleagues to make your training budget go further:

  • 30% off the 2nd delegate*
  • 40% off the 3rd delegate*
  • 50% off the 4th delegate*

Please contact us for pricing if you are interested in booking 5 or more delegates

15-17 May 2024

Live online

09:30-17:00 UK (London) (UTC+01)
10:30-18:00 Paris (UTC+02)
04:30-12:00 New York (UTC-04)
Course code 13652

  • GBP 1,499
  • EUR 2,149
  • USD 2,449

Limited places remaining

View basket 

 
Not ready to book yet?

for 7 days, no obligation

31 July-2 August 2024

Live online

09:30-17:00 UK (London) (UTC+01)
10:30-18:00 Paris (UTC+02)
04:30-12:00 New York (UTC-04)
Course code 13858

  • GBP 1,199 1,499
  • EUR 1,729 2,149
  • USD 1,981 2,449

Until 26 Jun

View basket 

 
Not ready to book yet?

for 7 days, no obligation

6-8 November 2024

Live online

09:30-17:00 UK (London) (UTC+00)
10:30-18:00 Paris (UTC+01)
04:30-12:00 New York (UTC-05)
Course code 14015

  • GBP 1,199 1,499
  • EUR 1,729 2,149
  • USD 1,981 2,449

Until 02 Oct

View basket 

 
Not ready to book yet?

for 7 days, no obligation

* Early booking discounts may not be combined with other discounts or offers. As such, the discounts for 2nd/3rd/4th delegates are based on the full price; and apply only when booking multiple delegates on the same date.

United Kingdom

  • 4D Pharma PLC
  • AbbVie Ltd
  • Aesica Queenborough Limited
  • Alacrita Consulting Ltd
  • Alander Consulting Limited
  • Allergan
  • Allergan UK Limited
  • Amersham Hospital
  • Amicus Therapeutics UK Limited
  • Antisoma Research Ltd
  • Arecor Limited
  • ARROW THERAPEUTICS LTD
  • AstraZeneca
  • AstraZeneca Pharmaceuticals Development
  • AstraZeneca Plc
  • AstraZeneca R&D Charnwood
  • BAUSCH & LOMB INC
  • Bayer Healthcare
  • Bespak Europe Limited
  • Biogen
  • Biogen Idec
  • Biogen IDEC Ltd
  • Biogen Idec Ltd., UK
  • Biogen Ltd
  • BioMarin International
  • BlueReg
  • Boehringer Ingelheim
  • Bristol-Myers Squibb Pharmaceuticals Ltd
  • Britannia Pharmaceuticals Ltd.
  • BTG International Ltd
  • Cardiff University
  • Celgene Europe Limited a Bristol Myers Squibb Company
  • Celgene Europe Ltd
  • Chiesi Ltd
  • Christina carnegie Consultancy
  • Chugai Pharma Europe Ltd
  • Clinigen Healthcare Ltd
  • ConvaTec UK Ltd
  • Dechra Veterinary Products
  • Eisai Limited
  • Eisai Ltd
  • Eisai Manufacturing Limited
  • Eli Lilly & Co Ltd
  • Evox Therapeutics Ltd
  • Fujifilm Kyowa Kirin Biologics
  • G-Pharm Ltd
  • Galapagos
  • Galen Ltd
  • Genzyme Therapeutics Ltd
  • Gilead Sciences International
  • Gilead Sciences International Limited
  • GlaxoSmithKline
  • GSK
  • GW Pharmaceuticals
  • GW PHARMACEUTICALS PLC
  • Hospira UK Limited
  • HRA Pharma UK & Ireland Ltd
  • Incyte
  • Indivior PharmaceuticalUK Ltd
  • Indivior UK Limited
  • Intercept Pharma Europe Ltd
  • Intercept Pharmaceuticals
  • Invicta Compliance
  • Janssen
  • Janssen Cilag Ltd
  • Johnson & Johnson
  • Johnson & Johnson Consumer Services EAME Ltd
  • Johnson & Johnson Limited
  • KINGSTON UNIVERSITY
  • LifeScientific
  • Martindale Pharma
  • Masters Speciality Pharma
  • Medimmune UK Limited
  • Medipro Consulting Ltd
  • MEDIS LIMITED
  • Merck Sharp & Dohme Ltd
  • Mitsubishi Tanabe Pharma Europe Ltd
  • MSD Animal Health
  • Mylan
  • NDA Regulatory Science Ltd
  • NHS
  • Nordic Pharma
  • NOVARTIS VACCINES
  • Owen Mumford Ltd
  • Parexel International
  • Pathway Intermediates
  • Pfizer
  • Pfizer Limited
  • PharmArchitecture Limited
  • PharmiWeb Solutions
  • PRA International Ltd
  • Prostrakan Group Ltd
  • PROTHERICS PLC
  • Quotient Clinical Ltd
  • R + D DIRECTORATE NHS GRAMPIAN
  • Recipharm
  • Reckitt Benckiser Health Care (UK) Ltd
  • Reckitt Benckiser Healthcare (UK) Ltd
  • Reckitt Benckiser International Limited
  • Red Line Pharmacovigilance
  • Red Line Pharmacovigilance Ltd
  • Regulink Ltd
  • ROCHE
  • Roche Product Ltd
  • Rosemont Pharma Ltd
  • Sales-Link, Inc.
  • Sanofi Pasteur MSD
  • Sanofi-Aventis
  • Sartorius-Stedim BioOutsource
  • SCHWARZ PHARMA Limited
  • Scottish National Blood Transfusion Service
  • Shire Pharmaceutical Ltd
  • SI Associates Ltd
  • Stiefel Labs (Maidenhead) Ltd
  • Strategic Consultants
  • Strathclyde Institute of Pharmacy and Biomedical Sciences
  • Takeda
  • Takeda Development Centre Europe Ltd
  • Takeda UK
  • Takeda UK Ltd
  • TEVA UK
  • Thomson Reuters
  • Thornton & Ross Ltd
  • Toray Industries Inc
  • Torbay and South Devon NHS Foundation Trust
  • Torbay Pharmaceuticals
  • UCB
  • UCB Pharma Limited
  • UCB Pharma Ltd
  • United Therapeutics Europe Ltd
  • UNIVERSITY OF CARDIFF
  • University of Strathclyde
  • University of Ulster
  • Vantia Limited
  • Vectura
  • Vectura Group plc
  • Vertex Pharmaceuticals (Europe) Limited
  • Veryan Medical Limited
  • Vifor Pharma UK Ltd
  • Waymade Healthcare plc
  • Winthrop Pharmaceuticals UK Ltd
  • Wyeth Europa Ltd

Switzerland

  • Vifor Pharma AG
  • Acino International AG
  • Alvotech Swiss AG
  • Amgen (Europe) GmbH
  • Ares Trading SA
  • BeiGene Switzerland
  • Covis Pharma
  • Covis Pharma BV
  • Crucell Switzerland AG
  • Elanco Animal Health
  • F. Hoffmann-La Roche Ltd
  • FISHER CLINICAL SERVICES GmbH
  • Helsinn Healthcare S.A.
  • IBSA Institut Biochimique SA
  • Lundbeck (Schweiz) AG
  • Merck Serono SA
  • Novartis Vaccines & Diagnostics AG
  • Novo Nordisk
  • Octapharma AG
  • Roche Pharma (Switzerland) AG
  • Santen SA
  • SERONO INTERNATIONAL SA
  • Serono Pharma International
  • SkyePharma AG
  • Takeda Pharmaceuticals International AG
  • Takeda Pharmaceuticals International GmbH
  • Vifor Pharma AG

Germany

  • ABBOTT GmbH & Co KG
  • Bayer AG
  • Bayer Aktiengesellschaft
  • Bayer Animal Health GmbH
  • Bayer Healthcare
  • Bayer Healthcare AG
  • Bayer Pharma AG
  • BIVRC GmbH & Co KG
  • Boehringer Ingelheim Veterinary Research Center GmbH & Co. KG
  • Boehringer Ingelheim Vetmedica GmbH
  • Boehringer Ingelheim VRC GmbH & Co. KG
  • Cesra Arzneimittel GmbH & Co
  • Cheplapharm
  • Cheplapharm Arzneimittel GmbH
  • Grunenthal GmbH
  • HEUMANN PHARMA GMBH & CO
  • Life Molecular Imaging GmbH
  • Medac GmbH
  • Merck KGaA
  • Mundipharma Deutschland GmbH & Co KG
  • Nordmark Arzeneimittel GmbH & Co KG
  • Pieris Pharmaceuticals GmbH
  • Sandoz International GmbH
  • SCIL TECHNOLOGY GmbH
  • Semigator GmbH
  • Takeda GmbH

Denmark

  • Albumedix Ltd
  • ALK
  • Alk Abello A/S
  • Boehringer-Ingelheim Danmark A/S
  • Coloplast A/S
  • Dako Denmark A/S
  • DANISH CANCER SOCIETY
  • Ferring Pharmaceuticals A/S
  • Genmab AS
  • LEO Pharma
  • LEO Pharma A/S
  • MERCK SHARP & DOHME
  • Merial Norden A/S
  • Neurosearch A/S
  • Novo Nordisk
  • Novo Nordisk A/S
  • Novo Nordisk AS
  • Novo Nordisk Scandinavia
  • NovoNordisk A/S
  • Takeda Pharma A/S
  • Xellia Pharmaceuticals ApS

France

  • IPSEN INNOVATION
  • Aeras Global TB Vaccine Foundation
  • Astrazeneca
  • Avadel Pharmaceuticals SA
  • Baxter SAS
  • Boehringer Ingelheim Animal Health France
  • GALDERMA R & D
  • Ipsen Consumer Healthcare SAS
  • IPSEN INNOVATION
  • Ipsen Pharma SAS
  • Laboratoires Fournier
  • LFB Biomedicaments
  • MEDINCELL
  • Sanofi-aventis
  • SANTEN
  • Teva Sante
  • Wyeth Pharmaceuticals

Netherlands

  • Abbott Biologicals BV
  • Abbott Healthcare Products BV
  • Abbott Vascular B.V.
  • Amgen Europe BV
  • Astellas Pharma Europe B.V.
  • Astellas Pharma Europe BV
  • BIOGEN IDEC BV
  • DADA Consultancy
  • FERRING BV
  • Merck Sharp & Dohme
  • Merus NV
  • Pfizer
  • Sanquin Plasma Products B.V.
  • Seqirus
  • Sun Pharma
  • Tjoapack Netherlands B.V.

Belgium

  • Aratana Therapeutics NV
  • Chiesi Group
  • Cyberonics Europe BVBA
  • Fujirebio-Europe NV
  • Galapagos NV
  • Glaxo Smithkline Biologicals
  • Janssen Infectious Diseases - Diagnostics BVBA
  • Janssen Pharmaceutica NV
  • Ortho Biotech, Johnson & Johnson
  • UCB Pharma SA
  • VIB
  • ViroVet BVBA

Austria

  • Baxter Innovations GmbH
  • Eli Lilly Regional Operations GmbH
  • Fresenius Kabi Austria GmbH
  • MED-EL Elektromedizinische Geräte GmbH
  • Octapharma Pharmazeutika Produktionsges.m.b.H.
  • Valneva Austria GmbH

Ireland

  • Alexion Pharmaceuticals
  • Alkermes
  • Alkermes Pharma Ireland Ltd
  • ENTERPRISE IRELAND
  • Pfizer Limited
  • Shire Pharmaceuticals Ireland Ltd

Italy

  • AbbVie
  • Chiesi Farmaceutical SpA
  • Chiron S.r.l
  • GlaxoSmithKline Vaccines & Diagnostics s.r.l.
  • Menarini Ricerche Spa
  • Zambon Company SpA

Spain

  • ALMIRALL, S.A.
  • Centro de Investigacion Farmaceutica
  • Chemo Espana SL
  • Faes Farma SA
  • Laboratorios Leti SL Unipersonal
  • PHARMACEUTICAL RESEARCH ASSOCIATES

Croatia

  • Agencije Za Lijekove I Medicinske Proizvode
  • Belupo d.d.
  • Europharma doo
  • EWOPHARMA d.o.o.
  • Pliva - Research & Development Ltd

Poland

  • GSK
  • PHYTOPHARM KLEKA SA
  • POLPHARMA GROUP
  • Polpharma SA
  • Radiometer Sp. z o.o.

Sweden

  • Astra Zeneca AB
  • LEO Pharma
  • Orexo AB
  • OTSUKA PHARMA SCANDINAVIA AB
  • Wellspect Healthcare

Canada

  • GSK Biologicals
  • Jubilant Draximage Inc.
  • LAURENENTIAN UNIVERSITY
  • Novocol Pharmaceutical of Canada Inc.

United States of America

  • Core Informatics
  • Genmab AS
  • Medexus
  • TITAN PHARMACEUTICALS INC

Egypt

  • Minapharm Pharmaceuticals
  • Rhein-Minapharm Biogenetics
  • Zoetis

Finland

  • Orion Corporation Orion Pharma
  • Orion Oyj Orion Pharma
  • Orion Pharma

Kuwait

  • Al Hafez Trading Est
  • Gharghour Arabian Gulf Co. w.I.I.
  • Yiaco Medical Co

Norway

  • Novo Nordisk AS
  • Pronova BioPharma

Portugal

  • BIAL - PORTELA & CA, S.A.
  • JABA FARMACEUTICA S.A

Saudi Arabia

  • Avalon Pharma
  • Saudi Food and Drug Authority

Turkey

  • BOEHRINGER INGELHEIM
  • Recordati Ilac Sanayi ve Ticaret Anonim Sirketi

United Arab Emirates

  • Hospira (ME & NA)
  • Newbridge Pharmaceuticals

Australia

  • Elanco

Bulgaria

  • ASSOCIATION OF BULGARIAN

Czech Republic

  • Pro-Med CS Praha AS

Ecuador

  • Grunenthal

Georgia

  • GEOPHARMA LIMITED

Iceland

  • Actavis Group PTC ehf.

India

  • MAK COLLEGE OF PHARMACY AND MAK LABS

Israel

  • Compugen Limited

Jordan

  • Pharma International Co - PIC

Lithuania

  • UAB GLAXOSMITHKLINE LIETUVA

Nigeria

  • Link Health Care Pharmacy Nigeria Limited

Romania

  • Arriello Group

Russia

  • Association of Clinical Trials Organizations

South Africa

  • AstraZeneca South Africa (Pty) Ltd

Tunisia

  • Laboratoires Galpharma

Yemen

  • Ibn Hayyan & Mohdar Co (Eisai Co Ltd)

Enrol or reserve

Run The Pharma Mini MBA Live online for your team

4 days

Typical duration

Pricing from:

  • GBP 1,400
  • Per attendee, based on 10 attendees
  • Course tailored to your requirements
  • At your choice of location, or online

 

We can customise this course to your requirements and deliver it on an in-house basis for any number of your staff or colleagues.

Contact our in-house training experts Aleksandra Beer and Yesim Nurko to discuss your requirements:

Multiple colleagues? See above for details of our discounts for 2, 3, or 4 delegates. For more, talk to one of our training experts to discuss how to:

Run this course conveniently and cost-effectively in-house for your staff and colleagues

Aleksandra Beer

Aleksandra BEER
Training expert

Yesim Nurko

Yesim NURKO
Training expert

+44 (0)20 7749 4749

inhouse@ipi.academy